Abstract
There have been numerous methods and ways to classify autoimmune diseases. By far, the most traditional has been to separate immune-mediated pathology into organ-specific and organ-non-specific diseases. The classic systemic autoimmune diseases are, of course, rheumatoid arthritis and systemic lupus. The classic organ-specific autoimmune diseases have been autoimmune thyroiditis and autoimmune gastritis. However, as our understanding of the loss of tolerance has expanded, so has the long list of autoimmune diseases. In many cases, the distinction between organ-specific and organ-non-specific or systemic autoimmunity becomes a blur. In this issue, we discuss recent concepts in autoimmune pancreatitis, primary sclerosing cholangitis, Goodpasture’s syndrome, myofasciitis, type I diabetes, polymyositis, autoimmune thyroid disease, IgA nephropathy, autoimmune uveitis, and ANCA-associated vasculitis. Common themes on both etiology and effector mechanisms are described throughout these papers with an attempt to provide a cutting-edge overview.
Similar content being viewed by others
References
Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258–J265
Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319–A324
Bhat A, Naguwa S, Cheema G, Gershwin ME (2010) The epidemiology of transverse myelitis. Autoimmun Rev 9:A395–A399
Biggioggero M, Meroni PL (2010) The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 9:A299–A304
Bizzaro N, Tozzoli R, Shoenfeld Y (2007) Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum 56:1736–1744
Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34:J287–J299
Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277–A287
Borchers AT, Uibo R, Gershwin ME (2010) The geoepidemiology of type 1 diabetes. Autoimmun Rev 9:A355–A365
Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207–J219
Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314–J321
Chang C (2010) The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 34:J234–J246
Chang C, Gershwin ME (2010) Drugs and autoimmunity—a contemporary review and mechanistic approach. J Autoimmun 34:J266–J275
Chen M, Daha MR, Kallenberg CG (2010) The complement system in systemic autoimmune disease. J Autoimmun 34:J276–J286
Chen M, Kallenberg CG (2010) The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 9:A293–A298
Deane S, Teuber SS, Gershwin ME (2010) The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 9:A342–A349
Ehrenfeld M (2010) Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 9:A325–A329
Gershwin ME, Goetzl EJ, Steinberg AD (1974) Cyclophosphamide: use in practice. Ann Intern Med 80:531–540
Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves’ disease: evidence of a genetic and an environmental contribution. J Autoimmun 34:J307–J313
Hershko AY, Naparstek Y (2006) Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 5:230–233
Hoffmann MH, Trembleau S, Muller S, Steiner G (2010) Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 34:J178–J206
Invernizzi P (2010) Geoepidemiology of autoimmune liver diseases. J Autoimmun 34:J300–J306
Lambert JF, Nydegger UE (2010) Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 9:A350–A354
Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH (2010) Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 9:A400–A405
Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266
Logan I, Bowlus CL (2010) The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 9:A372–A378
Mackay IR (2005) The etiopathogenesis of autoimmunity. Semin Liver Dis 25:239–250
Mackay IR (2010) Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 9:A251–A258
Martin PI, Malizia AI, Rewald E (2008) A propos time and autoimmunity. Clin Rev Allergy Immunol 34:380–384
Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H (2010) Light, including ultraviolet. J Autoimmun 34:J247–J257
Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sjogren’s syndrome. Autoimmun Rev 9:A305–A310
Meyer A, Levy Y (2010) Chapter 33: geoepidemiology of myasthenia gravis. Autoimmun Rev 9:A383–A386
Meyer N, Misery L (2010) Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 9:A379–A382
Milo R, Kahana E (2010) Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9:A387–A394
Powell JJ, Faria N, Thomas-McKay E, Pele LC (2010) Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34:J226–J233
Prieto S, Grau JM (2010) The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 9:A330–A334
Ranque B, Mouthon L (2010) Geoepidemiology of systemic sclerosis. Autoimmun Rev 9:A311–A318
Round JL, O’Connell RM, Mazmanian SK (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34:J220–J225
Sands J, Tuscano JM (2010) Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 9:A335–A341
Segelmark M, Hellmark T (2010) Autoimmune kidney diseases. Autoimmun Rev 9:A366–A371
Selmi C (2010) The worldwide gradient of autoimmune conditions. Autoimmun Rev 9:A247–A250
Selmi C, Tsuneyama K (2010) Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 9:A267–A270
Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168–J177
Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325–330
Stojanovich L (2010) Stress and autoimmunity. Autoimmun Rev 9:A271–A276
Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9:A288–A292
Tomer Y (2010) Hepatitis C and interferon induced thyroiditis. J Autoimmun 34:J322–J326
Tonutti E, Visentini D, Bizzaro N (2007) Interpretative comments on autoantibody tests. Autoimmun Rev 6:341–346
Youinou P, Pers JO, Gershwin ME, Shoenfeld Y (2010) Geo-epidemiology and autoimmunity. J Autoimmun 34:J163–J167
Zeki AA, Schivo M, Chan AL, Hardin KA, Kenyon NJ, Albertson TE et al (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34:J327–J338
Ambrosio P, Lermann R, Cordeiro A, Borges A, Nogueira I, Serrano F (2010) Lupus and pregnancy—15 years of experience in a tertiary center. Clin Rev Allergy Immunol 38:77–81
Ballestar E (2010) Epigenetics lessons from twins: prospects for autoimmune disease. Clin Rev Allergy Immunol 39:30–41
Blank M, Shoenfeld Y (2010) Antiphospholipid antibody—mediated reproductive failure in antiphospholipid syndrome. Clin Rev Allergy Immunol 38:141–147
Brooks WH (2010) X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 39:20–29
De Carolis S, Botta A, Santucci S, Garofalo S, Martino C, Perrelli A et al (2010) Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin Rev Allergy Immunol 38:116–124
Dieker J, Muller S (2010) Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol 39:78–84
Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, Bonfa E (2010) Immunogenicity of anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol 38:82–89
Grolleau-Julius A, Ray D, Yung RL (2010) The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol 39:42–50
Ikehara S (2010) The future of stem cell transplantation in autoimmune disease. Clin Rev Allergy Immunol 38:292–297
Ishii N, Hashimoto T, Zillikens D, Ludwig RJ (2010) High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases. Clin Rev Allergy Immunol 38:186–195
Katzav A, Shoenfeld Y, Chapman J (2010) The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol 38:196–200
Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y (2010) Evidence for the use of intravenous immunoglobulins—a review of the literature. Clin Rev Allergy Immunol 38:201–269
Meron MK, Amital H, Shepshelovich D, Barzilai O, Ram M, Anaya JM et al (2010) Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol 38:287–291
Perron H, Lang A (2010) The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol 39:51–61
Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A et al (2010) Sjogren syndrome or sjogren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 38:178–185
Renaudineau Y (2010) The revolution of epigenetics in the field of autoimmunity. Clin Rev Allergy Immunol 39:1–2
Renaudineau Y, Garaud S, Le Dantec C, Alonso-Ramirez R, Daridon C, Youinou P (2010) Autoreactive B cells and epigenetics. Clin Rev Allergy Immunol 39:85–94
Szyf M (2010) Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 39:62–77
Zhao S, Long H, Lu Q (2010) Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol 39:3–9
Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28–35
Kochi Y, Suzuki A, Yamada R, Yamamoto K (2010) Ethnogenetic heterogeneity of rheumatoid arthritis—implications for pathogenesis. Nat Rev Rheumatol 6:290–295
Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J et al (2009) Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 41:1319–1324
Rook GA (2011) Hygiene and other early childhood influences on the subsequent function of the immune system. Dig Dis 29:144–153
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P (2010) Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 9:494–498
Sebastiani GD, Galeazzi M (2009) Infection–genetics relationship in systemic lupus erythematosus. Lupus 18:1169–1175
Smyk D, Rigopoulou EI, Baum H, Burroughs AK, Vergani D, Bogdanos DP (2011) Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol. (in press)
Tsantikos E, Oracki SA, Quilici C, Anderson GP, Tarlinton DM, Hibbs ML (2010) Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J Immunol 184:1348–1360
Zenewicz LA, Abraham C, Flavell RA, Cho JH (2010) Unraveling the genetics of autoimmunity. Cell 140:791–797
Zouali M (2011) Epigenetics in lupus. Ann N Y Acad Sci 1217:154–165
Selmi C, Papini AM, Pugliese P, Alcaro MC, Gershwin ME (2011) Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis. Arch Med Sci 3:368–380
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gershwin, M.E., Shoenfeld, Y. Cutting-Edge Issues in Organ-Specific Autoimmunity. Clinic Rev Allerg Immunol 41, 123–125 (2011). https://doi.org/10.1007/s12016-011-8283-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-011-8283-x